RECEPTORS, FIBROBLAST GROWTH FACTOR

Clinical trials for RECEPTORS, FIBROBLAST GROWTH FACTOR explained in plain language.

Never miss a new study

Get alerted when new RECEPTORS, FIBROBLAST GROWTH FACTOR trials appear

Sign up with your email to follow new studies for RECEPTORS, FIBROBLAST GROWTH FACTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New bladder implant aims to zap cancer from the inside

Disease control Recruiting now

This study is testing a new device called TAR-210, which is placed in the bladder to slowly release a cancer drug called erdafitinib. The goal is to treat bladder cancer directly at the site, potentially controlling the disease while reducing side effects that can happen when the…

Matched conditions: RECEPTORS, FIBROBLAST GROWTH FACTOR

Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

RECEPTORS, FIBROBLAST GROWTH FACTOR

Get alerted when new RECEPTORS, FIBROBLAST GROWTH FACTOR trials appear

New bladder implant aims to zap cancer from the inside